XML 41 R26.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Selected Quarterly Financial Data | 12 Months Ended
--- | ---
Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract] |
Selected Quarterly Financial Data | 19. SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED) The following table presents selected unaudited consolidated financial data for each of the eight quarters in the two-year period ended December 31, 2016. The Company believes this information reflects all recurring adjustments necessary to fairly present this information when read in conjunction with the Company’s financial statements and the related notes. Net loss per share, basic and diluted, for the four quarters of each fiscal year may not sum to the total for the fiscal year because of the different number of shares outstanding during each period. The results of operations for any quarter are not necessarily indicative of the results to be expected for any future period. The acquisition of Allenex in the June 30, 2016 quarter affects the comparability of the financial data presented below.
Quarter Ended: |  | March 31 |  |  | June 30 |  |  | September 30 |  |  | December 31 |
|  | (In thousands, except share and per share data) |
2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consolidated Statement of Operations Data: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenue |  | $ | 6,562 |  |  | $ | 10,735 |  |  | $ | 12,475 |  |  | $ | 10,859 |
Net loss attributable to CareDx, Inc. used to compute basic net loss per share |  | $ | (9,752 | ) |  | $ | (10,470 | ) |  | $ | (3,764 | ) |  | $ | (15,483 | )
Net loss per common share attributable to CareDx, Inc., basic |  | $ | (0.81 | ) |  | $ | (0.77 | ) |  | $ | (0.20 | ) |  | $ | (0.73 | )
Net loss per common share attributable to CareDx, Inc., diluted |  | $ | (0.81 | ) |  | $ | (0.77 | ) |  | $ | (0.26 | ) |  | $ | (0.73 | )
Shares used in calculation of net loss per share attributable to CareDx, Inc., basic |  |  | 11,969,714 |  |  |  | 13,568,120 |  |  |  | 19,098,626 |  |  |  | 21,270,151 |
Shares used in calculation of net income loss per share attributable to CareDx, Inc., diluted |  |  | 11,969,714 |  |  |  | 13,568,120 |  |  |  | 19,481,424 |  |  |  | 21,270,151 |
Consolidated Balance Sheet Data: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total assets |  | $ | 48,834 |  |  | $ | 100,453 |  |  | $ | 102,092 |  |  | $ | 76,730 |
Long-term debt, net of current portion |  | $ | 11,368 |  |  | $ | 10,072 |  |  | $ | 8,496 |  |  | $ | 1,098 |
2015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consolidated Statement of Operations Data: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenue |  | $ | 7,216 |  |  | $ | 7,129 |  |  | $ | 7,151 |  |  | $ | 6,648 |
Net loss attributable to CareDx, Inc. used to compute basic net loss per share |  | $ | (2,272 | ) |  | $ | (3,185 | ) |  | $ | (3,489 | ) |  | $ | (4,761 | )
Net loss per common share attributable to CareDx, Inc., basic |  | $ | (0.19 | ) |  | $ | (0.27 | ) |  | $ | (0.29 | ) |  | $ | (0.40 | )
Net loss per common share attributable to CareDx, Inc., diluted |  | $ | (0.19 | ) |  | $ | (0.27 | ) |  | $ | (0.29 | ) |  | $ | (0.40 | )
Shares used in calculation of net loss per share attributable to CareDx, Inc., basic |  |  | 11,814,467 |  |  |  | 11,835,405 |  |  |  | 11,890,057 |  |  |  | 11,902,325 |
Shares used in calculation of net income loss per share attributable to CareDx, Inc., diluted |  |  | 11,814,467 |  |  |  | 11,835,405 |  |  |  | 11,890,057 |  |  |  | 11,902,325 |
Consolidated Balance Sheet Data: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total assets |  | $ | 63,277 |  |  | $ | 61,366 |  |  | $ | 59,342 |  |  | $ | 55,638 |
Long-term debt, net of current portion |  | $ | 14,609 |  |  | $ | 13,389 |  |  | $ | 12,125 |  |  | $ | 12,887 |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1570-108306 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration